Skip to content
Open Access
  • Home
  • Collections
    • High Impact Articles
    • Jawi Collection
    • Malay Medicine
    • Forensic
  • Search Options
    • UiTM Open Access
    • Search by UiTM Scopus
    • Advanced Search
    • Search by Category
  • Discovery Service
    • Sources
    • UiTM Journals
    • List UiTM Journal in IR
    • Statistic
  • About
    • Open Access
    • Creative Commons Licenses
    • COKI | Malaysia Open Access
    • User Guide
    • Contact Us
    • Search Tips
    • FAQs
Advanced
  • Search
  • Sotagliflozin, a dual SGLT1 an...
  • Cite this
  • Text this
  • Email this
  • Print
  • Export Record
    • Export to RefWorks
    • Export to EndNoteWeb
    • Export to EndNote
  • Permanent link
Sotagliflozin, a dual SGLT1 and SGLT2 inhibitor: In the heart of the problem

Sotagliflozin, a dual SGLT1 and SGLT2 inhibitor: In the heart of the problem

Bibliographic Details
Main Authors: Natalia G. Vallianou, Gerasimos Socrates Christodoulatos, Dimitris Kounatidis, Maria Dalamaga
Format: Article
Language:English
Published: Elsevier 2021-06-01
Series:Metabolism Open
Subjects:
Cardiovascular disease
Diabetes
Heart failure
Sodium glucose co-transporters inhibitor
Sotagliflozin
Online Access:http://www.sciencedirect.com/science/article/pii/S258993682100013X
  • Holdings
  • Description
  • Similar Items
  • Staff View

Internet

http://www.sciencedirect.com/science/article/pii/S258993682100013X

Similar Items

  • Sotagliflozin, an inhibitor of sodium–glucose cotransporters 1 and 2 (SGLT1/2), as a new therapeutic approach for patients with type 1 diabetes mellitus
    by: Mirella Czapska, et al.
    Published: (2018-12-01)
  • Efficacy of sodium-glucose co-transporter-2 inhibitors in patients with heart failure
    by: E. V. Kovalenko, et al.
    Published: (2021-02-01)
  • Sodium–glucose co-transporter 2 inhibitors as an early, first-line therapy in patients with heart failure and reduced ejection fraction
    by: Adamo, M., et al.
    Published: (2022)
  • Sotagliflozin, the first dual SGLT inhibitor: current outlook and perspectives
    by: Chiara Maria Assunta Cefalo, et al.
    Published: (2019-02-01)
  • Review on sodium-glucose cotransporter 2 inhibitor (SGLT2i) in diabetes mellitus and heart failure
    by: Akshyaya Pradhan, et al.
    Published: (2019-01-01)

© 2020 | Services hosted by the Perpustakaan Tun Abdul Razak, | Universiti Teknologi MARA | Disclaimer


Loading...